News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Still Wants AstraZeneca PLC (AZN) After $98.7 Billion Bid Rejected



4/28/2014 7:08:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Pfizer Inc. (PFE:US) proposed buying AstraZeneca Plc (AZN) for about 58.8 billion pounds ($98.7 billion) in what would rank as the biggest-ever takeover of a U.K. company and said it continues to be interested in a deal even after being spurned. Pfizer offered 46.61 pounds a share in cash and stock for London-based AstraZeneca last January, and AstraZeneca declined to pursue negotiations, New York-based company Pfizer said in a statement today. The proposal is about 14 percent above the April 25 close for AstraZeneca.

Help employers find you! Check out all the jobs and post your resume.

Read at Business Week
Read at New York Times
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES